Piper Sandler Maintains Overweight on Dyne Therapeutics, Lowers Price Target to $12
Piper Sandler analyst Edward Tenthoff maintains Dyne Therapeutics (NASDAQ:DYN) with a Overweight and lowers the price target from $16 to $12.
Stocks That Hit 52-Week Lows On Wednesday
On Wednesday, 807 companies reached new 52-week lows.
Dyne Therapeutics Q1 EPS $(0.69) Down From $(0.50) YoY
Dyne Therapeutics (NASDAQ:DYN) reported quarterly losses of $(0.69) per share. This is a 38 percent decrease over losses of $(0.50) per share from the same period last year.
Mid-Day Market Update: Nasdaq Tumbles 250 Points; Activision Blizzard Shares Jump
Midway through trading Tuesday, the Dow traded down 1.58% to 35,343.17 while the NASDAQ fell 1.70% to 14,640.00. The S&P also fell, dropping, 1.57% to 4,589.66.
Stocks That Hit 52-Week Lows On Friday
During Friday's session, 445 companies made new 52-week lows.
Stocks Hitting New 52-Week Lows Today
On Monday morning, 60 companies achieved new lows for the year.